These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1816558)

  • 1. Structure-activity relationships at 5-HT1A receptors: binding profiles and intrinsic activity.
    Nelson DL
    Pharmacol Biochem Behav; 1991 Dec; 40(4):1041-51. PubMed ID: 1816558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational flexibility of serotonin1A receptor ligands from crystallographic data. Updated model of the receptor pharmacophore.
    Chilmonczyk Z; Szelejewska-Wozniakowska A; Cybulski J; Cybulski M; Koziol AE; Gdaniec M
    Arch Pharm (Weinheim); 1997 May; 330(5):146-60. PubMed ID: 9237427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
    Cornfield LJ; Lambert G; Arvidsson LE; Mellin C; Vallgårda J; Hacksell U; Nelson DL
    Mol Pharmacol; 1991 Jun; 39(6):780-7. PubMed ID: 1828859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.
    Cozzi NV; Daley PF
    Bioorg Med Chem Lett; 2016 Feb; 26(3):959-964. PubMed ID: 26739781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships and molecular modeling studies of novel arylpiperazinylalkyl 2-benzoxazolones and 2-benzothiazolones as 5-HT(7) and 5-HT(1A) receptor ligands.
    Salerno L; Pittalà V; Modica MN; Siracusa MA; Intagliata S; Cagnotto A; Salmona M; Kurczab R; Bojarski AJ; Romeo G
    Eur J Med Chem; 2014 Oct; 85():716-26. PubMed ID: 25128671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the structural and mechanistic basis of function, classification, and ligand design for 5-HT receptors.
    Weinstein H; Osman R
    Neuropsychopharmacology; 1990; 3(5-6):397-409. PubMed ID: 2078275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,4-Benzoxazin-3(4H)-one derivatives and related compounds as 5-HT1A and 5-HT2A receptor ligands; the effect of the terminal amide fragment on the 5-HT1A/5-HT2A affinity and functional activity.
    Mokrosz MJ; Kowalski P; Kowalska T; Majka Z; Duszyńska B; Charakchieva-Minol S; Szaro A; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
    Pol J Pharmacol; 1998; 50(4-5):333-40. PubMed ID: 10091718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N4-unsubstituted N1-arylpiperazines as high-affinity 5-HT1A receptor ligands.
    Kuipers W; van Wijngaarden I; Kruse CG; ter Horst-van Amstel M; Tulp MT; IJzerman AP
    J Med Chem; 1995 May; 38(11):1942-54. PubMed ID: 7783126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
    López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
    J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzimidazolone-based serotonin 5-HT1A or 5-HT7R ligands: synthesis and biological evaluation.
    Badarau E; Suzenet F; Bojarski AJ; Fînaru AL; Guillaumet G
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1600-3. PubMed ID: 19237285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical models of interactions between buspirone analogues and 5-HT1A and 5-HT2A serotonin receptor subtypes.
    Bronowska A; Sylte I; Edvardsen Ø; Østensen R; Leś A; Chilmonczyk Z
    Acta Pol Pharm; 2000 Nov; 57 Suppl():40-5. PubMed ID: 11293260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of a new model of arylpiperazines. Study of the 5-HT(1a)/alpha(1)-adrenergic receptor affinity by classical hansch analysis, artificial neural networks, and computational simulation of ligand recognition.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Rosado ML; Pardo L; Schaper K
    J Med Chem; 2001 Jan; 44(2):198-207. PubMed ID: 11170629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model of the serotonin 5-HT1A receptor: agonist and antagonist binding sites.
    Kuipers W; Van Wijngaarden I; Ijzerman AP
    Drug Des Discov; 1994 Apr; 11(3):231-49. PubMed ID: 7548638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.
    Perrone R; Berardi F; Colabufo NA; Leopoldo M; Lacivita E; Tortorella V; Leonardi A; Poggesi E; Testa R
    J Med Chem; 2001 Dec; 44(25):4431-42. PubMed ID: 11728188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3D QSAR analysis of novel 5-HT1A receptor ligands].
    Borosy AP
    Acta Pharm Hung; 1998 Mar; 68(2):71-8. PubMed ID: 9592931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel 3-aminochromans as potential pharmacological tools for the serotonin 5-HT(7) receptor.
    Holmberg P; Tedenborg L; Rosqvist S; Johansson AM
    Bioorg Med Chem Lett; 2005 Feb; 15(3):747-50. PubMed ID: 15664850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
    Ransom RW; Asarch KB; Shih JC
    J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 5-HT1A and dopamine D2 pharmacophores. X-ray structures and affinities of conformationally constrained ligands.
    Chidester CG; Lin CH; Lahti RA; Haadsma-Svensson SR; Smith MW
    J Med Chem; 1993 May; 36(10):1301-15. PubMed ID: 8496900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
    Yocca FD; Iben L; Meller E
    Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.